136 related articles for article (PubMed ID: 6098205)
21. Bovine viral diarrhea virus with deletions in the 5'-nontranslated region: reduction of replication in calves and induction of protective immunity.
Makoschey B; Becher P; Janssen MG; Orlich M; Thiel HJ; Lütticken D
Vaccine; 2004 Sep; 22(25-26):3285-94. PubMed ID: 15308351
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
[TBL] [Abstract][Full Text] [Related]
24. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation).
Liess B; Orban S; Frey HR; Trautwein G; Wiefel W; Blindow H
Zentralbl Veterinarmed B; 1984 Oct; 31(9):669-81. PubMed ID: 6097070
[No Abstract] [Full Text] [Related]
25. Evolution of bovine viral diarrhea virus vaccines.
Kelling CL
Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):115-29. PubMed ID: 15062478
[TBL] [Abstract][Full Text] [Related]
26. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
27. Experimental production of bovine respiratory tract disease with bovine viral diarrhea virus.
Potgieter LN; McCracken MD; Hopkins FM; Walker RD; Guy JS
Am J Vet Res; 1984 Aug; 45(8):1582-5. PubMed ID: 6089623
[TBL] [Abstract][Full Text] [Related]
28. Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.
Dehan P; Couvreur B; Hamers C; Lewalle P; Thiry E; Kerkhofs P; Pastoret PP
Vaccine; 2005 Jul; 23(33):4236-46. PubMed ID: 16005739
[TBL] [Abstract][Full Text] [Related]
29. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine.
Packianathan R; Clough WJ; Hodge A; Holz DK; Huang J; Bryant GL; Colantoni C
N Z Vet J; 2017 May; 65(3):134-139. PubMed ID: 28359226
[TBL] [Abstract][Full Text] [Related]
30. Noncytopathic bovine viral diarrhea virus can persist in testicular tissue after vaccination of peri-pubertal bulls but prevents subsequent infection.
Givens MD; Riddell KP; Walz PH; Rhoades J; Harland R; Zhang Y; Galik PK; Brodersen BW; Cochran AM; Brock KV; Carson RL; Stringfellow DA
Vaccine; 2007 Jan; 25(5):867-76. PubMed ID: 17005300
[TBL] [Abstract][Full Text] [Related]
31. Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.
Brar JS; Johnson DW; Muscoplat CC; Shope RE; Meiske JC
Am J Vet Res; 1978 Feb; 39(2):241-4. PubMed ID: 204233
[TBL] [Abstract][Full Text] [Related]
32. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of acetylethyleneimine-killed bovine viral diarrhea-mucosal disease virus (BVD) vaccine for prevention of BVD infection of the fetus.
McClurkin AW; Coria MF; Smith RL
Proc Annu Meet U S Anim Health Assoc; 1975; (79):114-23. PubMed ID: 220623
[No Abstract] [Full Text] [Related]
34. Immunization against mucosal disease--bovine viral Diarrhea (MD-BVD) in calves applying lapinized vaccine against swine fever and a modified live virus of MD-BVD.
Haralambiev H; Tsvetkov P; Nikolov A; Gaytandgieva R
Arch Exp Veterinarmed; 1975; 29(5):701-4. PubMed ID: 180923
[TBL] [Abstract][Full Text] [Related]
35. Enzyme-linked immunosorbent assay assessment of bovine viral diarrhea virus antigen in inactivated vaccines using polyclonal or monoclonal antibodies.
Ludemann LR; Katz JB
Biologicals; 1994 Mar; 22(1):21-7. PubMed ID: 8068310
[TBL] [Abstract][Full Text] [Related]
36. Investigation on the incidence of bovine viral diarrhoea virus in calves born with encephalopathy in Turkey.
Alkan F; Burgu I
Dtsch Tierarztl Wochenschr; 1993 Mar; 100(3):107-9. PubMed ID: 8386080
[TBL] [Abstract][Full Text] [Related]
37. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
Platt R; Burdett W; Roth JA
Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
[TBL] [Abstract][Full Text] [Related]
38. Severe clinical disease induced in cattle persistently infected with noncytopathic bovine viral diarrhea virus by superinfection with cytopathic bovine viral diarrhea virus.
Bolin SR; McClurkin AW; Cutlip RC; Coria MF
Am J Vet Res; 1985 Mar; 46(3):573-6. PubMed ID: 2986494
[TBL] [Abstract][Full Text] [Related]
39. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
